These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

80 related articles for article (PubMed ID: 6198521)

  • 1. A humoral lymphocyte transformation inhibition factor in multiple sclerosis.
    Wernicke JF; Sweet PM; van den Noort S; Mayberg HS; Armentrout SA
    J Clin Lab Immunol; 1983 Dec; 12(4):187-95. PubMed ID: 6198521
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The effect of a factor from multiple sclerosis serum on isolated T and B lymphocytes.
    Armentrout SA; Sweet PM; Galant SP
    J Clin Lab Immunol; 1981 May; 5(3):133-6. PubMed ID: 6972451
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Inhibition of mitogen induced blast transformation by a multiple sclerosis serum factor.
    Anderson JA; Sweet P; Armentrout SA
    J Clin Lab Immunol; 1979 Nov; 2(4):285-91. PubMed ID: 537025
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Clinico-immunologic correlations in disseminated sclerosis].
    Zavalishin IA; Khondkarian OA; Nevskaia OM; Pivovarova AI
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1984; 84(2):164-7. PubMed ID: 6608842
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A mitogenic factor, released by stimulated human mononuclear cells and distinct from interleukin 2 (IL 2), B cell growth factor (BCGF), and interleukin 1 (IL 1).
    Kasakura S; Taguchi M; Watanabe Y; Okubo T; Murachi T; Uchino H; Hanaoka M
    J Immunol; 1984 Dec; 133(6):3084-90. PubMed ID: 6238094
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Characterization of a factor in leprosy serum that inhibits the growth of mitogen-stimulated normal human lymphocytes.
    Kerr MA; Hussein YM; Potts RC; Beck JS; Sheriff MM
    Immunology; 1987 Jun; 61(2):117-23. PubMed ID: 3596636
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Chemokines in multiple sclerosis: CXCL12 and CXCL13 up-regulation is differentially linked to CNS immune cell recruitment.
    Krumbholz M; Theil D; Cepok S; Hemmer B; Kivisäkk P; Ransohoff RM; Hofbauer M; Farina C; Derfuss T; Hartle C; Newcombe J; Hohlfeld R; Meinl E
    Brain; 2006 Jan; 129(Pt 1):200-11. PubMed ID: 16280350
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Biochemical characterization of lymphocyte regulatory molecules. II. Purification of a class of rat and human lymphokines.
    Gillis S; Smith KA; Watson J
    J Immunol; 1980 Apr; 124(4):1954-62. PubMed ID: 6444967
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Oral administration of type-II collagen peptide 250-270 suppresses specific cellular and humoral immune response in collagen-induced arthritis.
    Zhu P; Li XY; Wang HK; Jia JF; Zheng ZH; Ding J; Fan CM
    Clin Immunol; 2007 Jan; 122(1):75-84. PubMed ID: 17045846
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A human T cell-derived soluble factor able to suppress pokeweed mitogen-induced immunoglobulin production.
    Warrington RJ; Sauder PJ; Olivier SL; Rutherford WJ; Wilkins JA
    J Immunol; 1983 Jan; 130(1):237-41. PubMed ID: 6600180
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Effects of monoclonal antibodies directed against murine T lymphocyte cell surface antigens on lymphokine production by cloned T lymphocytes reactive with class I MHC or Mls alloantigens.
    Lancki DW; Prystowsky MB; Vogel SN; Beller DI; Dialynas DP; Fitch FW
    J Immunol; 1984 Oct; 133(4):2051-7. PubMed ID: 6236262
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Functional activity of lymphocytes in multiple sclerosis].
    Manovich ZKh; Seletskaia TA; Sysoeva KR
    Zh Nevropatol Psikhiatr Im S S Korsakova; 1979; 79(2):136-9. PubMed ID: 425755
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Lymphokines: their role in lymphocyte responses. Properties of interleukin 1.
    Oppenheim JJ; Stadler BM; Siraganian RP; Mage M; Mathieson B
    Fed Proc; 1982 Feb; 41(2):257-62. PubMed ID: 6800841
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Histamine-induced suppressor factor (HSF): inhibition of helper T cell generation and function.
    Garovoy MR; Reddish MA; Rocklin RE
    J Immunol; 1983 Jan; 130(1):357-61. PubMed ID: 6216286
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Purification of murine helper T cell-replacing factors.
    Watson J; Mochizuki D; Gillis S
    Prog Clin Biol Res; 1981; 66 Pt A():513-22. PubMed ID: 6975944
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Immunology of multiple sclerosis.
    Oger J; Roos R; Antel JP
    Neurol Clin; 1983 Aug; 1(3):655-79. PubMed ID: 6209537
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Mitogen-induced plasma cell differentiation in patients with multiple sclerosis.
    Levitt D; Griffin NB; Egan ML
    J Immunol; 1980 May; 124(5):2117-21. PubMed ID: 6965966
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Interferon-beta enhances monocyte and dendritic cell expression of B7-H1 (PD-L1), a strong inhibitor of autologous T-cell activation: relevance for the immune modulatory effect in multiple sclerosis.
    Schreiner B; Mitsdoerffer M; Kieseier BC; Chen L; Hartung HP; Weller M; Wiendl H
    J Neuroimmunol; 2004 Oct; 155(1-2):172-82. PubMed ID: 15342209
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Longitudinal analysis of immune cell phenotypes in early stage multiple sclerosis: distinctive patterns characterize MRI-active patients.
    Rinaldi L; Gallo P; Calabrese M; Ranzato F; Luise D; Colavito D; Motta M; Guglielmo A; Del Giudice E; Romualdi C; Ragazzi E; D'Arrigo A; Dalle Carbonare M; Leontino B; Leon A
    Brain; 2006 Aug; 129(Pt 8):1993-2007. PubMed ID: 16870883
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Cellular and humoral immune responses against autoreactive T cells in multiple sclerosis patients after T cell vaccination.
    Hermans G; Denzer U; Lohse A; Raus J; Stinissen P
    J Autoimmun; 1999 Sep; 13(2):233-46. PubMed ID: 10479392
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.